CMCR

Our third theme is technology development. We build on the fact that, in contrast to when the CMCR program was initiated, commercial high-throughput technologies for cell handling, gene expression, and metabolomics are now increasingly available in university, industry, and in clinical testing laboratories... In that we have developed high-throughput systems for using various biomarkers for biodosimetry, we also are in a unique position to probe the application of these biomarkers for predicting inter-individual sensitivity to acute radiation syndromes. This will enable us to examine correlations between our high-throughput biomarkers and individual late radiation sensitivity, specifically the severity of pneumonitis, and it will enable us to probe the associated mechanisms of individual radiation pneumonitis response and recovery... The National Institute of Allergies and Infectious Diseases (NIAID) (link is external and opens in a new window)was tasked with forming a research..

Primary location: New York United States